Talent - Study purpose



Thin strut sirolimus-eluting stent in All comers population vs Everolimus-eluting stent

A prospective multicenter randomized post market all-comer trial to assess the safety and effectiveness of the SUPRAFLEX sirolimus-eluting coronary stent system for the treatment of atherosclerotic lesion(s).

To compare the SUPRAFLEX SES with the XIENCE EES with respect to target lesion failure (TLF) at 12 months in a non-inferiority trial in a “real world” patient population